Stockreport

Seres Therapeutics: Much Better Risk-Reward At Current Price, But Still Risky [Seeking Alpha]

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF However, pending more updates on commercial uptake of VOWST and payer coverage risk remains high. Restructuring, including reduction of workforce by 41% and pausing R& [Read more]